The NHS in Wales has entered into a partnership with Illumina Cambridge Limited to build on existing research into lung cancer diagnostics.
They aim to expand into other cancer types, using genomics expertise to develop preventative, diagnostic and personalised treatments.
Suzanne Rankin, senior responsible officer for Genomics Partnership Wales, said: 'This is an incredibly exciting time for the field of genomic medicine, and I believe that the strategic collaboration of these organisations represents a fantastic opportunity for Wales to continue strengthening their position in this area.'
